Trial Profile
A phase III study of the use of a long term adjuvant hormonal treatment with LHRH analogue [gonadorelin] following a six months combined androgen blockade in locally advanced prostatic carcinoma treated by external radiation
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2005
Price :
$35
*
At a glance
- Drugs Gonadotropin releasing hormone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 21 Jul 2005 New trial record.